Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Other Non-Current Assets (2020 - 2022)

Historic Other Non-Current Assets for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $305000.0.

  • Atea Pharmaceuticals' Other Non-Current Assets changed 0.0% to $305000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $305000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $305000.0 for FY2021, which is 18504.67% up from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Other Non-Current Assets is $305000.0, which was down 0.0% from $305000.0 recorded in Q2 2022.
  • Atea Pharmaceuticals' Other Non-Current Assets' 5-year high stood at $1.6 million during Q3 2020, with a 5-year trough of $107000.0 in Q4 2020.
  • Its 3-year average for Other Non-Current Assets is $387777.8, with a median of $305000.0 in 2021.
  • Data for Atea Pharmaceuticals' Other Non-Current Assets shows a peak YoY increase of 18504.67% (in 2021) and a maximum YoY decrease of 8144.77% (in 2021) over the last 5 years.
  • Over the past 3 years, Atea Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $107000.0 in 2020, then skyrocketed by 185.05% to $305000.0 in 2021, then changed by 0.0% to $305000.0 in 2022.
  • Its Other Non-Current Assets was $305000.0 in Q3 2022, compared to $305000.0 in Q2 2022 and $305000.0 in Q1 2022.